Vesa-Pekka Lehto

Prof. Dr. Vesa-Pekka Lehto

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLLizhi Liu
Lizhi Liu
DPDingyi Pan
Dingyi Pan
SCSheng Chen
Sheng Chen
MMMaria-Viola Martikainen
Maria-Viola Martikainen
Anna KårlundAnna Kårlund
Anna Kårlund
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Cell membrane (CM) coating technology is increasingly being applied in nanomedicine, but the entire coating procedure including adsorption, rupture, and fusion is not completely understood. Previously, we showed that the majority of biomimetic nanoparticles (NPs) were only partially coated, but the mechanism underlying this partial coating remains unclear, which hinders the further improvement of the coating technique. Here, we show that partial coating is an intermediate state due to the adsorption of CM fragments or CM vesicles, the latter of which could eventually be ruptured under external force. Such partial coating is difficult to self-repair to achieve full coating due to the limited membrane fluidity. Building on our understanding of the detailed coating process, we develop a general approach for fixing the partial CM coating: external phospholipid is introduced as a helper to increase CM fluidity, promoting the final fusion of lipid patches. The NPs coated with this approach have a high ratio of full coating (~23%) and exhibit enhanced tumor targeting ability in comparison to the NPs coated traditionally (full coating ratio of ~6%). Our results provide a mechanistic basis for fixing partial CM coating towards enhancing tumor accumulation.

26 October 2020 in Nanotechnology
Verified
Journal Article
Open access
XZXiuyun Zhao
Xiuyun Zhao
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Batteries are commonly considered one of the key technologies to reduce carbon dioxide emissions caused by the transport, power, and industry sectors. We need to remember that not only the production of energy needs to be realized sustainably, but also the technologies for energy storage need to follow the green guidelines to reduce the emission of greenhouse gases effectively. To reach the sustainability goals, we have to make batteries with the performances beyond their present capabilities concerning their lifetime, reliability, and safety. To be commercially viable, the technologies, materials, and chemicals utilized in batteries must support scalability that enables cost-effective large-scale production. As lithium-ion battery (LIB) is still the prevailing technology of the rechargeable batteries for the next ten years, the most practical approach to obtain batteries with better performance is to develop the chemistry and materials utilized in LIBs—especially in terms of safety and commercialization. To this end, silicon is the most promising candidate to obtain ultra-high performance on the anode side of the cell as silicon gives the highest theoretical capacity of the anode exceeding ten times the one of graphite. By balancing the other components in the cell, it is realistic to increase the overall capacity of the battery by 100%–200%. However, the exploitation of silicon in LIBs is anything else than a simple task due to the severe material-related challenges caused by lithiation/delithiation during battery cycling. The present review makes a comprehensive overview of the latest studies focusing on the utilization of nanosized silicon as the anode material in LIBs.

18 July 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
APAgnieszka Paściak
Agnieszka Paściak
RMRiccardo Marin
Riccardo Marin
LALise Abiven
Lise Abiven
APAleksandra Pilch-Wróbel
Aleksandra Pilch-Wróbel
MMMałgorzata Misiak
Małgorzata Misiak
ABArtur Bednarkiewicz
Artur Bednarkiewicz
Functional colloidal nanoparticles capable of converting between various energy types are finding an increasing number of applications. One of the relevant examples concerns light-to-heat-converting colloidal nanoparticles that may be useful for localized photothermal therapy of cancers. Unfortunately, quantitative comparison and ranking of nanoheaters are not straightforward as materials of different compositions and structures have different photophysical and chemical properties and may interact differently with the biological environment. In terms of photophysical properties, the most relevant information to rank these nanoheaters is the light-to-heat conversion efficiency, which, along with information on the absorption capacity of the material, can be used to directly compare materials. In this work, we evaluate the light-to-heat conversion properties of 17 different nanoheaters belonging to different groups (plasmonic, semiconductor, lanthanide-doped nanocrystals, carbon nanocrystals, and metal oxides). We conclude that the light-to-heat conversion efficiency alone is not meaningful enough as many materials have similar conversion efficiencies─in the range of 80-99%─while they significantly differ in their extinction coefficient. We therefore constructed their qualitative ranking based on the external conversion efficiency, which takes into account the conventionally defined light-to-heat conversion efficiency and its absorption capacity. This ranking demonstrated the differences between the samples more meaningfully. Among the studied systems, the top-ranking materials were black porous silicon and CuS nanocrystals. These results allow us to select the most favorable materials for photo-based theranostics and set a new standard in the characterization of nanoheaters.

2 July 2012 in Langmuir
Verified
Journal Article
Closed access
JRJoakim Riikonen
Joakim Riikonen
MSMikko Salomäki
Mikko Salomäki
JWJessica van Wonderen
Jessica van Wonderen
Marianna L KemellMarianna L Kemell
Marianna L Kemell
Wujun XuWujun Xu
Wujun Xu
VLVesa-Pekka Lehto
Vesa-Pekka Lehto

5 October 2015 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Wujun XuWujun Xu
Wujun Xu
RTRinez Thapa
Rinez Thapa
DLDongfei Liu
Dongfei Liu
TNTuomo Nissinen
Tuomo Nissinen
SGSari Granroth
Sari Granroth
VLVesa-Pekka Lehto
Vesa-Pekka Lehto

1 January 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JRJoakim Riikonen
Joakim Riikonen
Wujun XuWujun Xu
Wujun Xu
VLVesa-Pekka Lehto
Vesa-Pekka Lehto